AzTrials
AzTrials

Chronic Low-back PainNCT05972369

Sensory Nerve Function and Exercise Therapy Response in Chronic Low Back Pain

An observational study of Chronic Low-back Pain, run by Ahram Canadian University at 1 site in Egypt.

Unknown status

Status not confirmed. The sponsor has not verified this record for over two years, so it may be out of date.

Official record
Search all trials

Trial summary

This observational study aims to compare measures of sensory nerve function between chronic low back pain patients matched for baseline pain and disability levels who are then classified as responders or non-responders after completing a 12-week tailored exercise program. Read more about this study

Who is it for?
Ages 18 to 60 years
Conditions the study is for
Chronic Low-back Pain
What is being tested?
12-Week Tailored Exercise Intervention
How many people
50 participants
Where
1 siteEgypt
Study dates
1 Aug 2023to 15 Mar 2024
Phase
Observational
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 to 60 years
  • All sexes
  • No healthy volunteers
  • Adult

Study population: Adults with chronic nonspecific low back pain matched for baseline pain and disability levels.

Who may be able to join

  • Adults ages 20-60 years
  • Nonspecific chronic low back pain >3 months
  • Baseline pain ≥6/10 and disability ≥40%

Who cannot join

  • Radicular leg pain
  • Prior lumbar surgery
  • Serious spinal pathology

Trial locations and contacts

1 site in 1 country.

Mohamed M ElMeligie, Ph.d contact

+201064442032

mohamed.elmeligie@acu.edu.eg

Egypt1 site, 1 recruiting
  • Outpatient clinic of faculty of physical therapy, Ahram Canadian University

    Al Ḩayy Ath Thāmin, Giza Governorate, 3221405

    Mohamed M ElMeligie, Ph.d, 01064442032, mohamed.elmeligie@acu.edu.eg

    Recruiting

Other trials in Egypt

About this study

Official title: Comparing Sensory Nerve Conduction and Quantitative Sensory Testing Thresholds Between Matched Patients With Nonspecific Low Back Pain Categorized as Responders or Non-Responders to Exercise Therapy

This observational study aims to compare measures of sensory nerve function between chronic low back pain patients matched for baseline pain and disability levels who are then classified as responders or non-responders after completing a 12-week tailored exercise program. Measures collected include sural sensory nerve conduction, quantitative sensory testing for pressure and heat pain thresholds, and psychosocial questionnaires. It is hypothesized that baseline sensory nerve dysfunction may be associated with reduced response to exercise therapy in chronic low back pain.

Read the detailed description

While exercise is commonly prescribed for chronic nonspecific low back pain (NSLBP), patient responses are variable. Differences in baseline sensory nerve function could plausibly contribute to exercise therapy outcomes. This cross-sectional quantitative observational study will investigate if baseline sensory nerve conduction amplitudes and quantitative sensory testing (QST) pain thresholds differ between matched NSLBP patients later categorized as responders or non-responders to a 12-week standardized exercise regime. A sample of 50 NSLBP participants with matched baseline pain and disability will undergo a tailored 12-week exercise intervention and 6-month follow-up. Blinded assessors will perform post-intervention sensory nerve conduction and QST measures. It is hypothesized that exercise therapy responders will show greater improvements in sensory thresholds correlating with pain relief. Results aim to elucidate neural factors associated with long-term exercise therapy outcomes in chronic low back pain.

Being tested
12-Week Tailored Exercise Intervention

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • 12-Week Tailored Exercise InterventionOther

    12-week individually tailored exercise therapy program based on patient presentation. Supervised physiotherapy plus home exercise

Study groups in NCT05972369
Study groupRoleWhat they receive
Exercise Responders≥30% improvement in pain with 12 weeks of prescribed exercise
Receives: Other: 12-Week Tailored Exercise Intervention
Exercise Non-responders<30% improvement in pain with 12 weeks of prescribed exercise
Receives: Other: 12-Week Tailored Exercise Intervention

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Sural Sensory Nerve Conduction Amplitude

    Baseline antidromic sural sensory nerve action potential amplitude (measured in microvolts) assessed through nerve conduction study.

    Measured: Baseline

Secondary outcomes (3)
  1. Superficial Peroneal Sensory Nerve Conduction Amplitude

    Baseline superficial peroneal sensory nerve action potential amplitude (measured in microvolts) assessed through nerve conduction study.

    Measured: Baseline

  2. Pressure Pain Threshold

    Pressure pain threshold (measured in kg/cm2) assessed using a pressure algometer at the lower back.

    Measured: Baseline

  3. Heat Pain Threshold

    Heat pain threshold (measured in °C) assessed using a thermode applied to the calf.

    Measured: Baseline

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted2 Aug 2023
  2. Study start1 Aug 2023 (estimated)
  3. Primary completion1 Jan 2024 (estimated)
  4. Study completion15 Mar 2024 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Observational
Observational model
Other
Time perspective
Cross-sectional
Enrolment
50 participants (estimated)
IDs, dates and publications
ClinicalTrials.gov ID
NCT05972369
Sponsor's protocol ID
012/0701LBP02
Status last verified
Jul 2023
First submitted
24 Jul 2023
Last updated
2 Aug 2023
Results posted
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
No

Questions about this trial

What is this clinical trial studying?

An observational study of Chronic Low-back Pain, run by Ahram Canadian University at 1 site in Egypt.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 3 inclusion and 3 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: status not confirmed, as of the sponsor's last update on 2 Aug 2023. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in Egypt. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

Results are not available in the source record.

How can a doctor refer a patient or contact the research team?

Contact Mohamed M ElMeligie, Ph.d (+201064442032, mohamed.elmeligie@acu.edu.eg), or a site near the patient. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Sural Sensory Nerve Conduction Amplitude (time frame: Baseline). It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 2 Aug 2023.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in